Comprehensive analysis of disease spectrum and mortality in Sanjad–Sakati syndrome: an international rare disease registry study
The Journal of Clinical Endocrinology & Metabolism · 2026
DOI: 10.1210/clinem/dgag226 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift The Journal of Clinical Endocrinology & Metabolism, 2026. Verfasst von Angham Almutair und 19 weiteren Autor:innen. Beteiligte Einrichtung: Endocrinology Division, Department of Pediatrics, King Abdullah Specialized Children's Hospital (KASCH), King Abdulaziz Medical City, Ministry of Nat…. Hauptthemen laut MEDLINE: Abnormalities, Multiple, Craniofacial Abnormalities, Growth Disorders, Hypoparathyroidism. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
Context
Sanjad–Sakati syndrome (SSS), also known as hypoparathyroidism–intellectual disability–dysmorphism syndrome, is a rare autosomal recessive disorder caused by a TBCE founder mutation. The full disease spectrum remains poorly understood.
Objectives
To comprehensively analyze growth, phenotype, endocrine manifestations, and mortality in a large multicenter SSS cohort.
Methods
Clinical and genetic data were collected from 135 individuals across centers in the Gulf region using a REDCap survey.
Results
The median age at inclusion was 9.1 years (range: birth−30 years; 50.3% female). The homozygous TBCE founder mutation (c.155_166del; p.Ser52_Gly55del) was detected in all genetically tested individuals (n = 68). Intrauterine growth restriction (mean birth weight −3.0 SD, length −3.3 SD) and dysmorphic features were universal. Postnatal growth showed severe failure to thrive during infancy, followed by persistently low height z-scores (−7 to −8). Endocrine features included hypoparathyroidism in all patients, primary hypothyroidism (16.5%), hypoglycemia (27.8%), nonautoimmune insulin-dependent diabetes (1.6%) and pituitary hormone deficiencies. Other findings included developmental delay (100%), hypocalcemic seizures (64.2%), tetany (53.3%), nephrocalcinosis (62.1%), gastroesophageal reflux (29.1%), and recurrent respiratory (63.7%) and bacterial infections (53.8%). Antibiotic prophylaxis was used in 35% of patients. Kaplan–Meier analysis estimated a median survival of 27.2 years, with respiratory failure causing 84% of deaths (21/25). The estimated overall survival at an age of 18 years was 62.4%.
Conclusion
This largest reported SSS cohort highlights the high prevalence of associated endocrine, respiratory, and gastrointestinal manifestations, with respiratory failure as the leading cause of death. These data support the need for multidisciplinary care guidelines.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Endocrinology Division, Department of Pediatrics, King Abdullah Specialized Children's Hospital (KASCH), King Abdulaziz Medical City, Ministry of National Guard Health Affairs (MNG-HA), Riyadh, Saudi Arabia KSAU-HS, 785…
- College of Medicine, King Saud Bin Abdulaziz University for Health Sciences (KSAU-HS), Ministry of National Guard Health Affairs (MNGHA), 7850 Riyadh, Saudi Arabia.
- King Abdullah International Medical Research Center, Ministry of National Guard Health Affairs (MNGHA), 11481 Riyadh, Saudi Arabia.
- Department of Paediatrics and Adolescent Medicine, Johannes Kepler University Linz, 4020 Linz, Austria.
- Department of Pediatrics, College of Medicine, King Saud University, 11451 Riyadh, Saudi Arabia.
- Department of Pediatrics, King Faisal Specialist Hospital and Research Center, 11211 Riyadh, Saudi Arabia.
ORCID-Profile: Angham Almutair, Wolfgang Högler
Zitieren
APA
Almutair, A., Karas, K., Al Subaihin, A., Al Dibasi, O., Melha, M., Al-Ghamdi, H., Yadav, B., Al Ghanam, S., Alanazi, A., AlSaedi, A., Althobaiti, E., Al Senani, A., Al Azkawi, H., Al Enezi, A., Bakkar, A., Ali, A., Al Juraibah, F., Alyaarubi, S., Al Sagheir, A., & Högler, W. (2026). Comprehensive analysis of disease spectrum and mortality in Sanjad–Sakati syndrome: an international rare disease registry study. The Journal of Clinical Endocrinology & Metabolism. https://doi.org/10.1210/clinem/dgag226
Vancouver
Almutair A, Karas K, Al Subaihin A, Al Dibasi O, Melha M, Al-Ghamdi H, et al. Comprehensive analysis of disease spectrum and mortality in Sanjad–Sakati syndrome: an international rare disease registry study. The Journal of Clinical Endocrinology & Metabolism. 2026. doi:10.1210/clinem/dgag226
BibTeX
@article{Almutair2026,
author = {Almutair, Angham and Karas, Katharina and Al Subaihin, Abdulmajeed and Al Dibasi, Omar and Melha, Maali and Al-Ghamdi, Hadeel and Yadav, Bijesh and Al Ghanam, Suliman and Alanazi, Aisha and AlSaedi, Abdulaziz and Althobaiti, Enad and Al Senani, Aisha and Al Azkawi, Hanan and Al Enezi, Ayed and Bakkar, Ayman and Ali, Ahmed and Al Juraibah, Fahad and Alyaarubi, Saif and Al Sagheir, Afaf and Högler, Wolfgang},
title = {Comprehensive analysis of disease spectrum and mortality in Sanjad–Sakati syndrome: an international rare disease registry study},
journal = {The Journal of Clinical Endocrinology & Metabolism},
year = {2026},
doi = {10.1210/clinem/dgag226}
}
EUVIMED